发明申请
![[6,6] FUSED BICYCLIC HDAC8 INHIBITORS](/docs/US/2017-03-09/US20170066729A1/abs.jpg.600x600.jpg)
- 专利标题： [6,6] FUSED BICYCLIC HDAC8 INHIBITORS
- 专利标题（中）： [6,6] FUSED BICYCLIC HDAC8抑制剂
-
申请号： US15255817申请日： 2016-09-02
-
公开(公告)号： US20170066729A1公开(公告)日： 2017-03-09
- 发明人: Xiaozhang Zheng , Pui Yee Ng , Jennifer R. Thomason , Mary-Margaret Zablocki , Bingsong Han , Nicholas Barczak , Cuixian Liu , Aleksandra Rudnitskaya , David R. Lancia, JR. , Kenneth W. Bair
- 申请人： Forma Therapeutics, Inc.
- 主分类号： C07D265/36
- IPC分类号： C07D265/36 ; C07D413/06 ; C07D401/04 ; C07D279/16 ; C07D265/34 ; C07D413/10 ; C07D471/04 ; C07D417/06 ; C07D513/04 ; C07D487/04 ; C07D413/12 ; C07D491/107
![[6,6] FUSED BICYCLIC HDAC8 INHIBITORS](/abs-image/US/2017/03/09/US20170066729A1/abs.jpg.150x150.jpg)
摘要：
The present invention is directed to compounds of Formula I: and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, tautomers, or isomers or thereof, wherein R1, R2, R2′, L, X, W, Y1, Y2, Y3, and Y4 are described herein.
公开/授权文献
- US10029995B2 [6,6] fused bicyclic HDAC8 inhibitors 公开/授权日：2018-07-24
信息查询
